{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:03:32Z","timestamp":1781759012911,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003969","name":"Iranian Ministry of Health and Medical Education","doi-asserted-by":"crossref","award":["700\/534"],"award-info":[{"award-number":["700\/534"]}],"id":[{"id":"10.13039\/501100003969","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10787-022-01065-0","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T07:02:45Z","timestamp":1663138965000},"page":"2107-2116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of the relationship between opioid addiction and metabolic syndrome and its components in the adult population from Rafsanjan city; a cohort study"],"prefix":"10.1007","volume":"30","author":[{"given":"Zahra","family":"Bagheri-Hosseinabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Hakimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8149-8549","authenticated-orcid":false,"given":"Mitra","family":"Abbasifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"1065_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KGMM Alberti","year":"2006","unstructured":"Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome\u2014a new world-wide definition a consensus statement from the international diabetes federation. Diabet Med 23:469\u2013480","journal-title":"Diabet Med"},{"key":"1065_CR2","first-page":"193","volume":"5","author":"A Aliverdinia","year":"2006","unstructured":"Aliverdinia A (2006) A sociological study of drug addiction in Iran. Soc Welf Quart 5:193\u2013212","journal-title":"Soc Welf Quart"},{"key":"1065_CR3","unstructured":"Bafghi SS, Rafiei M, Bahadorzadeh L, Namayeh S, Soltani M, Andishmand MMA (2005) Is opium addiction a risk factor for acute myocardial infarction? Acta Medica Iranica 43:218\u2013222"},{"key":"1065_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40200-020-00492-6","volume":"19","author":"A Bahar","year":"2020","unstructured":"Bahar A et al (2020) Prevalence of metabolic syndrome using international diabetes federation, National Cholesterol Education Panel-Adult Treatment Panel III and Iranian criteria: results of Tabari cohort study. J Diabetes Metab Disorders 19:1\u20137","journal-title":"J Diabetes Metab Disorders"},{"key":"1065_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4103\/ijem.IJEM_617_17","volume":"22","author":"YPS Balhara","year":"2018","unstructured":"Balhara YPS, Jain R, Kuppili PP, Shukla A, Chawla N, Gupta R (2018) Which criteria to use to identify metabolic syndrome among patients with addictive disorders?: observations among patients with alcohol and opioid dependence syndrome. Indian J Endocrinol Metab 22:565","journal-title":"Indian J Endocrinol Metab"},{"key":"1065_CR6","first-page":"48","volume":"1","author":"G Davoodi","year":"2006","unstructured":"Davoodi G, Sadeghian S, Akhondzadeh S, Darvish S, Alidoosti M, Amirzadegan A (2006) Comparison of specifications, short term outcome and prognosis of acute myocardial infarction in opium dependent patients and nondependents. J Tehran Univ Heart Center 1:48\u201353","journal-title":"J Tehran Univ Heart Center"},{"key":"1065_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-6-4","volume":"6","author":"S Dhuper","year":"2007","unstructured":"Dhuper S, Cohen HW, Daniel J, Gumidyala P, Agarwalla V, St Victor R, Dhuper S (2007) Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study. Cardiovasc Diabetol 6:1\u20139","journal-title":"Cardiovasc Diabetol"},{"key":"1065_CR8","doi-asserted-by":"publisher","unstructured":"el-Guebaly N, Violato C (2021) International Society of Addiction Medicine\u2019s international certification of addiction medicine: the first 15 years. In: el-Guebaly N, Carr\u00e0 G, Galanter M, Baldacchino AM (eds) Textbook of addiction treatment. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-030-36391-8_59","DOI":"10.1007\/978-3-030-36391-8_59"},{"key":"1065_CR9","first-page":"792","volume":"13","author":"KK Farmanfarma","year":"2019","unstructured":"Farmanfarma KK, Kaykhaei MA, Adineh HA, Mohammadi M, Dabiri S, Ansari-Moghaddam A (2019) Prevalence of metabolic syndrome in Iran: a meta-analysis of 69 studies diabetes & metabolic syndrome. Clin Res Rev 13:792\u2013799","journal-title":"Clin Res Rev"},{"key":"1065_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jpm.12166","volume":"22","author":"M Flynn","year":"2015","unstructured":"Flynn M, Houtjes W, Merks A, Van Mierlo A, Van De Wetering B (2015) Metabolic syndrome in mental health and addiction treatment: a quantitative study. J Psychiatr Ment Health Nurs 22:15\u201319","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"1065_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","volume":"2","author":"PL Huang","year":"2009","unstructured":"Huang PL (2009) A comprehensive definition for metabolic syndrome. Dis Models Mech 2:231\u2013237","journal-title":"Dis Models Mech"},{"key":"1065_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/13556210410001674095","volume":"9","author":"GA Karam","year":"2004","unstructured":"Karam GA, Reisi M, Kaseb AA, Khaksari M, Mohammadi A, Mahmoodi M (2004) Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus. Addict Biol 9:53\u201358","journal-title":"Addict Biol"},{"key":"1065_CR13","first-page":"341","volume":"134","author":"SK Mattoo","year":"2011","unstructured":"Mattoo SK, Chakraborty K, Basu D, Ghosh A, Vijaya Kumar KG, Kulhara P (2011) Prevalence and correlates of metabolic syndrome in alcohol and opioid dependent inpatients. Indian J Med Res 134:341\u2013348","journal-title":"Indian J Med Res"},{"key":"1065_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.etp.2008.08.001","volume":"61","author":"A Mohammadi","year":"2009","unstructured":"Mohammadi A, Darabi M, Nasry M, Saabet-Jahromi M-J, Malek-Pour-Afshar R, Sheibani H (2009) Effect of opium addiction on lipid profile and atherosclerosis formation in hypercholesterolemic rabbits. Exp Toxicol Pathol 61:145\u2013149","journal-title":"Exp Toxicol Pathol"},{"key":"1065_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drugalcdep.2007.10.008","volume":"94","author":"F Passetti","year":"2008","unstructured":"Passetti F, Clark L, Mehta M, Joyce E, King M (2008) Neuropsychological predictors of clinical outcome in opiate addiction. Drug Alcohol Depend 94:82\u201391","journal-title":"Drug Alcohol Depend"},{"key":"1065_CR16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/aje\/kwx314","volume":"187","author":"H Poustchi","year":"2018","unstructured":"Poustchi H et al (2018) Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Epidemiol 187:647\u2013655","journal-title":"Am J Epidemiol"},{"key":"1065_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-018-0812-z","volume":"20","author":"MG Saklayen","year":"2018","unstructured":"Saklayen MG (2018) The global epidemic of the metabolic syndrome. Curr Hypertens Rep 20:1\u20138","journal-title":"Curr Hypertens Rep"},{"key":"1065_CR18","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1002\/mpr.244","volume":"17","author":"N Scherbaum","year":"2008","unstructured":"Scherbaum N, Specka M (2008) Factors influencing the course of opiate addiction. Int J Methods Psychiatr Res 17:S39\u2013S44","journal-title":"Int J Methods Psychiatr Res"},{"key":"1065_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/08897077.2017.1363122","volume":"39","author":"G Vallecillo","year":"2018","unstructured":"Vallecillo G et al (2018) Metabolic syndrome among individuals with heroin use disorders on methadone therapy: prevalence, characteristics, and related factors. Subst Abuse 39:46\u201351","journal-title":"Subst Abuse"},{"key":"1065_CR20","first-page":"26","volume":"41","author":"H Zhou","year":"2012","unstructured":"Zhou H et al (2012) An exploratory analysis of dynamic change of metabolic syndrome in relation to the risk of developing cardiovascular disease in a Chinese cohort Iranian. J Public Health 41:26","journal-title":"J Public Health"},{"key":"1065_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3923\/jas.2005.380.382","volume":"5","author":"H Ziaaddini","year":"2005","unstructured":"Ziaaddini H, Ziaaddini MR (2005) The household survey of drug abuse in Kerman. Iran J Appl Sci 5:380\u2013382","journal-title":"Iran J Appl Sci"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-01065-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T20:09:35Z","timestamp":1669406975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-01065-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-01065-0","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics committee of Rafsanjan University of Medical Sciences and all individuals voluntarily signed a written informed consent form. All methods were performed in accordance with the relevant guidelines and regulations by Rafsanjan University of Medical Sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}